Innovations in Immunology: Drug resistance is a constant threat to progress in HIV, TB and malaria vaccines

September 3, 2019

Despite global efforts at prevention and improving control, the public health impact of these diseases is still huge. Medicines are the mainstay of control efforts, but drug resistance is a constant threat. Effective vaccines are urgently required and would add substantially to the ongoing efforts to curb these diseases.

The first vaccine against malaria to receive a positive opinion from the European Medicines Agency will soon be tested in implementation trials in three African countries: Kenya, Malawi and Ghana.

Read the full article here

More News

Visit the IUIS Booth at the IUIS 2025 Congress!

July 29, 2025

A message from IUIS President, Dr Miriam Merad

July 2, 2025

Congratulations to the Winners of the 2025 Day of Immunology Awards

June 30, 2025

Is there an IEI you want to see in the next IUIS IEI classification? Submit it to us now!

June 16, 2025Inborn Errors of Immunity Committee (IEI)

Meet the IUIS 2025 Rising Stars!

June 12, 2025Early Career Committee (ECC)

Teaching Sustainable Development Goals: Methods for Education

May 20, 2025Immunotherapy Committee (ITH), Education Committee (EDU)

Apply Now: Michelson Prizes – $150,000 Grants for Emerging Leaders in Immunology

May 13, 2025Early Career Committee (ECC)

Announcing the 2025 Excellence in Immunology Award Winner: Dr. Arlene Sharpe

May 5, 2025Gender Equity Committee (GEC)

IUIS Invites Bids to Host the 21st Congress of the International Union of Immunological Societies (IUIS2031)

April 29, 2025